Loading clinical trials...
Loading clinical trials...
Epicardial Left Atrial Appendage Clipping Versus Novel Oral Anticoagulants to Reduce Stroke Risk in Non-paroxysmal Atrial Fibrillation: a Multicenter Randomized Controlled Trial
Conditions
Interventions
Thoracoscopic LAA clipping
Novel oral anticoagulant
Locations
1
China
China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China
Start Date
April 2, 2024
Primary Completion Date
April 1, 2028
Completion Date
May 1, 2028
Last Updated
June 13, 2024
Lead Sponsor
China National Center for Cardiovascular Diseases
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions